Research programme: VLP-based viral vaccines - Novavax
Alternative Names: Rabies vaccine - NovavaxLatest Information Update: 17 May 2019
At a glance
- Originator Novavax
- Class Protein vaccines; Recombinant fusion proteins; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rabies
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Rabies(Prevention) in USA (Parenteral)
- 09 May 2013 Preclinical trials in Rabies (prevention) in USA (Parenteral)
- 01 May 2012 Early research is ongoing in USA